AEON Biopharma, Inc. Share Price & Technical Analysis
AEON · $0.78 (-4.88%)
Healthcare / Biotechnology
$0.78
-4.88%
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastro…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 4 years shown)
-11% return in May, -3% avg return in past 3 year May month.
-29% return in 2026, -66% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | -8% | -9% | -10% | -11% | – | – | – | – | – | – | – | -29% |
| 25 | -75% | -90% | -14% | -33% | 50% | 33% | -12% | 0% | 14% | 13% | -11% | 38% | -90% |
| 24 | 0% | 65% | -9% | -48% | -59% | -33% | 65% | -51% | 31% | -13% | -41% | -4% | -96% |
| 23 | 0% | -4% | 1% | 0% | 1% | -31% | 10% | -27% | 5% | -5% | 10% | 27% | -13% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$23.15M
P/E ratio
—
52W high
$1.45
52W low
$0.53
Volume
1,33,701
Beta
0.66
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is AEON Biopharma, Inc. share price today?
- AEON Biopharma, Inc. (AEON) last traded around $0.78 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AEON have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AEON. Download the app for real-time alerts.
- How can I analyze AEON Biopharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.